...In 1790, the cost to obtain a patent was between $4 and $5.
Make the Most of PatentStorm
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest patents by subscribing to an RSS feed.
Got questions? Ask a Patent Expert!
Registered users: Manage your profile, comments and alerts.
AbstractThe present invention concerns a vaccine comprising a novel canine parvovirus strain and having the property of being able to break through the maternally derived antibody levels persistent in 9-12 week old pups, and even to immunize the majority of pups at the age of 6 weeks in the presence of maternally derived antibodies.Other References
| InventorAssigneeApplicationNo. 06/823333 filed on 01/28/1986US Classes:424/201.1, Combination of viral and bacterial antigens (e.g., multivalent viral and bacterial vaccine, etc.)424/233.1, Adenoviridae, adeno-like virus, or Parvoviridae (e.g., adenovirus, canine parvovirus, mink enteritis virus, hemorrhagic enteritis virus, feline panleukopenia virus, egg drop syndrome virus, etc.)424/818, VIRAL VACCINE FOR CANIDAE OR MUSTELIDAE (E.G., DOGS, FOXES, MINKS, ETC.)435/235.1, VIRUS OR BACTERIOPHAGE, EXCEPT FOR VIRAL VECTOR OR BACTERIOPHAGE VECTOR; COMPOSITION THEREOF; PREPARATION OR PURIFICATION THEREOF; PRODUCTION OF VIRAL SUBUNITS; MEDIA FOR PROPAGATING435/236Inactivation or attenuation; producing viral subunitsExaminersPrimary: Kepplinger, Esther M.Attorney, Agent or FirmUS Patent References4303645Modified living canine parvovirus vaccineIssued on: 12/01/1981 Inventor: Carmichael , et al. International ClassesA61K 39/295 (20060101)C07K 14/005 (20060101) C07K 14/015 (20060101) A61K 39/00 (20060101) Foreign Application Priority Data1985-01-31 GB |